WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007095513) TETRAHYDR0-2H-INDAZ0LE DERIVATIVES FOR USE AS CANNABINOID MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/095513    International Application No.:    PCT/US2007/062020
Publication Date: 23.08.2007 International Filing Date: 13.02.2007
IPC:
C07D 231/56 (2006.01), C07D 403/12 (2006.01), C07D 409/04 (2006.01), A61K 31/416 (2006.01), A61P 25/04 (2006.01)
Applicants: JANSSEN PHARMACEUTICA, NV [BE/BE]; Turnhoutseweg 30, B-2340 Beerse (BE) (For All Designated States Except US).
LIOTTA, Fina [US/US]; (US) (For US Only).
LU, Huajun [CN/US]; (US) (For US Only).
WACHTER, Michael, P. [US/US]; (US) (For US Only)
Inventors: LIOTTA, Fina; (US).
LU, Huajun; (US).
WACHTER, Michael, P.; (US)
Agent: JOHNSON, Philip, S.; Johnson & Johnson, One Johnson & Johnson Plaza, New Brunswick, NJ 08933 (US)
Priority Data:
60/773,184 14.02.2006 US
Title (EN) TETRAHYDR0-2H-INDAZ0LE DERIVATIVES FOR USE AS CANNABINOID MODULATORS
(FR) MODULATEURS CANNABINOIDES DE TYPE TETRAHYDRO-2H-INDAZOLE PYRAZOLE
Abstract: front page image
(EN)This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula: (I); or a form thereof, wherein p, R1, R2 and Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
(FR)La présente invention concerne un composé modulateur cannabinoïde de type tétrahydro-2H-indazole pyrazole de formule (I), ou une forme de celui-ci, dans laquelle p, R1, R2 et Ar sont définis comme indiqué ci-dessus et * représente un centre chiral, et un procédé permettant de traiter, atténuer ou prévenir un syndrome, une maladie ou un trouble induit par un récepteur cannabinoïde.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)